JP2008500963A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500963A5 JP2008500963A5 JP2007503063A JP2007503063A JP2008500963A5 JP 2008500963 A5 JP2008500963 A5 JP 2008500963A5 JP 2007503063 A JP2007503063 A JP 2007503063A JP 2007503063 A JP2007503063 A JP 2007503063A JP 2008500963 A5 JP2008500963 A5 JP 2008500963A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- antigen
- mixed
- immunomodulatory oligonucleotide
- tcttrctgtct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55287104P | 2004-03-12 | 2004-03-12 | |
| PCT/US2005/008238 WO2005089231A2 (en) | 2004-03-12 | 2005-03-11 | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008500963A JP2008500963A (ja) | 2008-01-17 |
| JP2008500963A5 true JP2008500963A5 (enExample) | 2008-05-15 |
Family
ID=34994209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007503063A Pending JP2008500963A (ja) | 2004-03-12 | 2005-03-11 | 第二世代免疫調節性オリゴヌクレオチドを用いて増幅されたｈｉｖワクチン活性 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050266015A1 (enExample) |
| EP (1) | EP1729802A4 (enExample) |
| JP (1) | JP2008500963A (enExample) |
| CN (1) | CN101217973A (enExample) |
| AU (1) | AU2005222909B2 (enExample) |
| CA (1) | CA2557443A1 (enExample) |
| WO (1) | WO2005089231A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
| CN1753687A (zh) | 2002-10-29 | 2006-03-29 | 科勒制药集团股份有限公司 | Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用 |
| MY159370A (en) | 2004-10-20 | 2016-12-30 | Coley Pharm Group Inc | Semi-soft-class immunostimulatory oligonucleotides |
| US7470674B2 (en) * | 2005-11-07 | 2008-12-30 | Idera Pharmaceuticals, Inc. | Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| KR101251707B1 (ko) | 2006-09-27 | 2013-04-11 | 콜리 파마슈티칼 게엠베하 | 면역 자극 활성이 증강된 소수성 Ｔ 유사체를 함유하는 ＣｐＧ 올리고뉴클레오티드 유사체 |
| BR112012030337B1 (pt) * | 2010-05-28 | 2021-04-27 | Coley Pharmaceutical Group, Inc | Vacina compreendendo um ou mais oligonucleotídeo(s) de cpg isolado(s) ou um agonista de tlr e colesterol, e uso da mesma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5912332A (en) * | 1996-07-26 | 1999-06-15 | Hybridon, Inc. | Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides |
| KR101123489B1 (ko) * | 2003-01-16 | 2012-03-28 | 이데라 파마슈티칼즈, 인코포레이티드 | 개질된 면역자극성 디뉴클레오티드를 이용한 올리고뉴클레오티드-기재 화합물의 면역자극 특성의 조절 |
| CN101291691A (zh) * | 2003-08-28 | 2008-10-22 | 免疫反应公司 | 免疫原性hiv组合物和相关方法 |
-
2005
- 2005-03-11 AU AU2005222909A patent/AU2005222909B2/en not_active Ceased
- 2005-03-11 JP JP2007503063A patent/JP2008500963A/ja active Pending
- 2005-03-11 CA CA002557443A patent/CA2557443A1/en not_active Abandoned
- 2005-03-11 WO PCT/US2005/008238 patent/WO2005089231A2/en not_active Ceased
- 2005-03-11 CN CNA2005800079845A patent/CN101217973A/zh active Pending
- 2005-03-11 US US11/078,654 patent/US20050266015A1/en not_active Abandoned
- 2005-03-11 EP EP05725427A patent/EP1729802A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007095976A3 (de) | Adjuvanz in form einer lipid-modifizierten nukleinsäure | |
| MX2010008468A (es) | Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante. | |
| JP2006316072A5 (enExample) | ||
| EP1766096A4 (en) | SIV AND HIV VACCINATION WITH RHCMV AND HCMV BASED IMPFECTORS | |
| JP2005237328A5 (enExample) | ||
| JP2009539965A5 (enExample) | ||
| JP2003503454A5 (enExample) | ||
| RU2007127993A (ru) | Сахарид-конъюгатные вакцины | |
| NZ585674A (en) | Vaccination with multiple clades of h5 influenza a virus | |
| JP2003526662A5 (enExample) | ||
| JP2007533729A5 (enExample) | ||
| RU2013119946A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| WO2007057763A3 (en) | Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant | |
| JP2007509902A5 (enExample) | ||
| EP2302059A8 (en) | Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization | |
| EA201101432A1 (ru) | Активный фармацевтический ингредиент, адсорбированный на твердой подложке | |
| JP2008500963A5 (enExample) | ||
| WO2009042895A3 (en) | Reagents for inducing an immune response | |
| JP2009514840A5 (enExample) | ||
| WO2005076001A3 (en) | A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual | |
| WO2005021726A3 (en) | Immunogenic hiv compositions and related methods | |
| JP2009505991A5 (enExample) | ||
| WO2005089231A3 (en) | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide | |
| JP2009514527A5 (enExample) | ||
| EP1905449A3 (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |